TTNP
Titan Pharmaceuticals, Inc.
4.6100
-0.1800-3.76%
Oct 1, 4:00:00 PM EDT

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
6.13M
P/E (TTM)
-
Basic EPS (TTM)
-2.92
Dividend Yield
0%

Recent Filings

About 

As of October 1, 2025, Titan Pharmaceuticals, Inc. was acquired by KE Sdn Bhd, in a reverse merger transaction. Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.

CEO
Mr. Weei Jye Chay
IPO
1/18/1996
Website
https://www.titanpharm.com
Sector
Healthcare
Industry
Biotechnology

Related Companies  

CURX
Curanex Pharmaceuticals Inc
0.41-0.02
ENZN
Enzon Pharmaceuticals, Inc.
0.05+0.00
EPIX
ESSA Pharma Inc.
0.20+0.00
NBY
NovaBay Pharmaceuticals, Inc.
3.16+0.45
PTIX
Protagenic Therapeutics, Inc.
1.52-0.07
PTPI
Petros Pharmaceuticals, Inc.
0.01-0.00
SMNR
Semnur Pharmaceuticals Inc.
9.00+0.00
TENX
Tenax Therapeutics, Inc.
11.16+0.55
TVRD
Tvardi Therapeutics, Inc.
4.20-0.02
XCUR
Exicure, Inc.
6.06+0.33